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A B S T R A C T
Purpose: Low-grade neuroepithelial tumors are frequent neuropathological ﬁndings in patients with
pharmacoresistant epilepsies. Little is known regarding epileptogenic mechanisms in this group of
neoplasms with gangliogliomas (GG) as the most common entity. Presence of hemosiderin deposits in
GG points to impairment of the blood-brain barrier (BBB). Therefore, we hypothesized a potential role of
BBB dysfunction and astrocytic albumin uptake as potential epileptogenic factor in GG.
Methods: Prussian blue staining and ﬂuorescent double-immunohistochemistry with antibodies against
albumin, GFAP, CD34 and GLUT-1 were used to analyze hemosiderin deposits and astroglial albumin
accumulation in tumor and adjacent pre-existing brain tissue of GG (n = 10) and several control groups,
i.e. dysembryoplastic neuroepithelial tumors (DNT; n = 5), focal cortical dysplasia with balloon cells (FCD
IIb; n = 10), astrocytomas WHO grade II (n = 5) and clear renal cell carcinoma brain metastases (RCCM,
n = 6).
Results: Our results revealed strong hemosiderin deposits in GG. Intriguingly, we noted substantial
albumin uptake exclusively in neoplastic glial cell components of GG and DNT, whereas no signiﬁcant
albumin was present in perilesional reactive astrocytes. Strikingly, we did not observe substantial
albumin uptake in further controls.
Conclusion: Glial albumin uptake was restricted to long-term epilepsy associated, vasculature-
containing tumors. Intratumoural BBB dysfunction in concert with subsequent accumulation of
albumin by neoplastic glial cell elements represent a new putatively epileptogenic mechanism for long-
term epilepsy-associated tumors.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Gangliogliomas (GG) represent the most frequent tumor entity
in young patients undergoing surgery for drug-refractory epilep-
sy.1 GG commonly correspond to WHO grade I tumors and are
histopathologically characterized by dysplastic neurons and
neoplastic astroglial cells. Typically, contrast enhancement is
present on magnetic resonance imaging (MRI) pointing to blood-
brain barrier (BBB) dysfunction. Mechanisms underlying the high
epileptogenicity of GG are still enigmatic.
Factors such as impaired neurochemical homeostasis, genetic
and peritumoural changes have been suggested to underlie* Corresponding author at: Department of Neuropathology, University of Bonn
Medical Center, Sigmund-Freud-Str. 25, 53105 Bonn, Germany.
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http://dx.doi.org/10.1016/j.seizure.2012.10.014increased neuronal excitability.2,3 Recent data emphasized a
contribution of BBB leakage to the progression of epilepsy,4–6
with astroglial albumin uptake as a key pathogenic factor.4,7,8
Frequent deposits of hemosiderin indicate an impairment of the
BBB in this tumor entity.
Accordingly, we analyzed hemosiderin deposits and astroglial
albumin accumulation in tumor and adjacent brain tissue of GG
and in several ‘control’ pathologies.
2. Materials and methods
2.1. Patients and surgical specimens
Biopsy specimens were obtained from patients who under-
went neurosurgery at the University of Bonn using controls as
follows. Dysembryoplastic neuroepithelial tumors (DNT; WHO
grade I) represent a further highly epilepsy-associated glioneur-
onal tumor entity. Diffuse astrocytomas (DA; WHO grade II)vier Ltd. All rights reserved.
Table 1B
Summarized lesional characteristics.
GGa/DNTb FCD IIbc Astrocytomad RCCMe
Impaired BBBf Yes No No Yes
Glial tumor cell component Yes No Yes No
Chronic epilepsy Yes Yes No No
Astroglial albumin uptake Yes No No No
a Ganglioglioma WHO grade I.
b Dysembryoplastic neuroepethelial tumor complex variant.
c Focal cortical dysplasia type IIb.
d Astrocytoma WHO grade II.
e Cerebral metastases of clear renal cell cancer.
f As indicated by hemosiderin deposits and contrast enhancement.
Table 1A
Clinical and neuropathological parameters of patients.
Patient no. Sex Therapy-refractory
epilepsy
Epilepsy
duration (yrs)
Age at
surgery (yrs)
Site of specimen
collection
Astrocytic albumin
uptakea
Hemosiderin
deposits
Lesion Perilesion Lesion Perilesion
Ganglioglioma (GG, WHO grade I)
1 f Yes 26 30 Temporal left ++ 0 ++ 0
2 f Yes 15 31 Temporal left ++ 0 ++ 0
3 f Yes 15 39 Frontal right + 0 + 0
4 m Yes 3 6 Frontal left ++ 0 ++ 0
5 m Yes 38 51 Temporal left ++ 0 ++ +
6 m Yes 2 17 Temporal right ++ 0 + 0
7 m Yes 2 12 Temporal left ++ 0 + 0
8 f Yes 13 36 Temporal right +++ 0 0 0
9 m Yes 3 39 Temporal left ++ + + 0
10 m Yes 1 20 Temporal right + 0 0 0
Dysembryoplastic neuroepethelial tumor (DNT, WHO grade I)
11 f Yes 5 20 Frontal left + 0 0 0
12 m Yes 7 54 Temporal left + 0 + 0
13 m Yes 50 59 Frontal left ++ 0 ++ +
14 m Yes 10 35 Temporal right + 0 + 0
15 f Yes 1 28 Frontal left + 0 0 0
Focal cortical dysplasia type IIb (FCD IIb)
16 f Yes 8 9 Parietal left 0 0 0 0
17 f Yes 2 9 Temporal left 0 0 0 0
18 m Yes 10 10 Insula left 0 0 0 0
19 m Yes 11 13 Parietal left + 0 0 0
20 f Yes 13 32 Temporal right + 0 0 +
21 m Yes 2 2 Temporal left 0 0 0 0
22 m Yes 6 7 Parietal left 0 0 + 0
23 f Yes 15 17 Frontal left 0 0 0 0
24 f Yes 9 23 Frontal right 0 0 0 0
25 m Yes 14 22 Parietal left + 0 0 0
Astrocytoma (WHO grade II)
26 f No 45 Temporal left 0 0 0 0
27 f No 20 Temporal right 0 0 0 0
28 m No 36 Insula right 0 0 0 0
29 m No 33 Temporal left 0 0 0 0
30 f No 50 Frontal left 0 0 0 0
Renal cell carcinoma metastasis (RCCM)
31 f No 61 Frontal left / + + 0
32 m No 65 Temporal left / 0 ++ +
33 m No 57 Frontal left / 0 +++ +++
34 f No 69 Temporal left / + ++ 0
35 f No 43 Frontal left / 0 + +
36 m No 44 Temporal left / 0 + 0
a Astrocytic albumin storage as observed in lesional and perilesional areas of gangliogliomas, DNT, FCD IIb and astrocytomas. Due to mainly absent astrocytes in lesional
regions of carcinoma metastasis, only the perilesional brain tissue was considered for examination.
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in GG but lack contrast enhancement and the strong association
with drug-refractory epilepsy. Focal cortical dysplasias with
balloon cells (FCD IIb) represent non-neoplastic epilepsy-
associated lesions without a vascular component.9 Finally, clear
renal cell carcinoma brain metastases (RCCM) often encounter
neuropathological hemosiderin deposits and contrast enhance-
ment on MRI. Here, seizures are rather acute than chronic (GG:
n = 10; DNT: n = 5; FCD IIb: n = 10; DA: n = 5; RCCM: n = 6). All
procedures were carried out in accordance with the declaration
of Helsinki. The clinical parameters of the patients are summa-
rized in Table 1A.
2.2. Tissue processing, immunohistochemistry, double-
immunoﬂuorescence and image analysis
These procedures were performed as described before,10 see
Appendix A for more details. Prussian blue staining and GFAP/
albumin double-immunoﬂuorescence labeling was used in all
cases to analyze semiquantitatively (none, few, intermediate,abundant) hemosiderin deposits and astrocytic albumin uptake in
lesional and perilesional regions (Tables 1A and 1B). Representa-
tive neuropathological ﬁndings for the different groups are shown
in Figs. A1–A3.
Fig. 1. Representative GFAP/albumin double-immunohistochemistry in gangliogliomas and speciﬁc controls. (A) Neoplastic astrocytes in GG show co-localization of GFAP
(red) and albumin (green) as visualized in the merge image (see circles in A). In contrast, other astrocytic differentiated cells, as they are (B) perilesional reactive astrocytes
adjacent to GG, (C) reactive astrocytes in FCD IIb, (D) neoplastic astrocytes in DA and (E) reactive astrocytes adjacent to RCCM express GFAP (red) but are generally not
immunoreactive with antibodies against albumin (merged images, B–E). However, multifocal intravascular albumin enhancement can be observed in most cases (arrows in
A–D). Characteristic balloon cells in FCD IIb show partly GFAP expression, but no albumin uptake is detectable (insert in C). Transition region to the carcinoma metastasis can
be clearly identiﬁed by high cell density in the metastasis (asterisks in E). Scale bars: A–E = 100 mm; Insert in C = 50 mm. (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of the article).
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Lesional regions of GG were mostly positive for hemosiderin
with a variation from none (n = 2) over few (n = 4) to intermediate
(n = 4) deposits. In perilesional regions few (n = 1) to none (n = 9)
hemosiderin amount were detected (Tables 1A and 1B). We
observed astrocytic deposits of albumin in all GG varying from
abundant (n = 1) over intermediate (n = 7) to few (n = 2; Fig. 1A).
Linear regression analysis showed no correlation between albumin
accumulation and duration of epilepsy (R2 = 0.019; p = 0.7). In
perilesional regions we found less (n = 1) to none (n = 9) albumin
uptake (Fig. 1B). Glucose transporter-1 (GLUT-1) is highly co-
localized with CD-34 in vascular endothelial cells, but lacks
differences in lesional versus perilesional tissue of GG or in
comparison to other entities (Fig. A4).
In FCD IIb, hemosiderin deposits were exceptional, both in
lesional (n = 1) and perilesional (n = 1) tissue. GFAP/albumin
double-immunohistochemistry showed no substantial albumin
uptake in the lesional and perilesional areas (n = 7, Fig. 1C). Only in
three cases (n = 3), we observed few albumin in astrocytes. CD34/
albumin co-stainings conﬁrmed mainly intravascular localizationof albumin in FCD IIb (Fig. A5A). In DA, neither hemosiderin nor
astrocytic albumin deposits were present in lesional or perilesional
regions (n = 5; Figs. 1D and A5B).
Intralesional hemosiderin deposits varied in RCCM between
few (n = 3), intermediate (n = 2) and abundant (n = 1). In perile-
sional tissue none (n = 3), few (n = 2) or abundant (n = 1)
accumulation of hemosiderin was present. Analysis of GFAP/
albumin co-staining revealed none (n = 4) or few (n = 2) astrocytic
albumin uptake in adjacent CNS (Tables 1A and 1B, Figs. 1E and
A5C). Obviously, no relevant number of intratumoural asctrocytes
is present in RCCMs.
In three DNT samples intralesional hemosiderin deposits were
observed. Relevant albumin accumulation in perivascular glial
elements were present in all cases, but mostly low (Fig. A3).
Perilesional astrocytes showed no deﬁnite albumin uptake. Neither
DNTnorGGwere associated withperilesional focalcortical dysplasia.
4. Discussion
Although composed of highly similar cellular components,
the epileptogenicity of individual low grade brain neoplasms is
Fig. A1. Neuroradiological and histopathological ﬁndings in gangliogliomas and FCD IIb. In a representative case of GG, coronal T2-weighted (A), T1-weighted contrast
enhanced (B), and FLAIR fast spin echo (C) magnetic resonance images show a superior temporal gyrus and insular lesion (white arrows) with calciﬁcation (hypointense areas
in A and C, proven by CT (not shown)) and contrast enhancement. Microscopically a mixture of glial and neuronal cells with focal calciﬁcations (black arrow) can be identiﬁed
(D, Hematoxylin/Eosin (H&E) staining). The neuronal component is represented by dysplastic neurons, which show prominent Nissl substance and lack uniform orientation.
Bi- or multi-nucleate neurons may also be observed (Insert in D). A perisomatic expression of synaptophysin is a frequent observed feature of dysplastic neurons in GG (E,
white arrowheads) The glial component is represented by astrocytic differentiated cells with strong expression of glial ﬁbrillary acidic protein (GFAP, F). Multifocal
hemosiderin deposits demonstrate blood-brain barrier (BBB) dysfunction within the tumor tissue (G, Prussian blue staining). CD34-immunoreactive cells with intense
ramiﬁcation of processes (satellite cells) represent a further feature of GG (H). H and E staining of a representative FCD IIb (I) shows characteristic histopathological features as
the presence of dysmorphic neurons (white arrowheads in I–K) and balloon cells (black arrowheads in I–K). Immunohistochemical analysis reveals strong expression of
vimentin (J), but absence of MAP2 immunoreactivity (K) in balloon cells, whereas dysmorphic neurons are negative for vimentin and positive for MAP2. Hemosiderin deposits
are usually absent in FCD IIb (L). Coronal T2-weighted fast spin echo (M), sagittal 3D T1-weighted gradient echo (N), and coronal FLAIR fast spin echo (O) images show a large
insular and parietal dysplasia with subcortical FLAIR and T2 hyperintensity suggestive of a FCD type 2B. Scale bars: D = 50 mm (applies also to F, G-L); Insert in D and
E = 25 mm.
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to the diffusely inﬁltrating growth pattern of DAs, these tumors
are not highly epileptogenic. In fact, circumscribed primary
brain tumors, particularly GG are most frequently associated
with chronic epilepsy. This has been primarily claimed to rely
on the presence of dysmorphic neurons within the tumor
resulting in imbalances of neurotransmitters, receptors and ion
channels.3 Although these factors may indeed contribute to
epileptogenicity, some aspects argue for additional relevant
factors. Firstly, removal of the tumor does not always result in
seizure relief. Secondly, also pure vascular lesions such as
cavernomas are highly epileptogenic. Only recently BBB-dysfunction and albumin storage by adjacent reactive astroglia
have been described in human epileptic tissue and claimed as
pathogenetic factors.10
Here, we observed uptake of albumin by intratumoural
astroglial cells in GG that from their cellular shape and distribution
pattern have to be categorized as neoplastic astroglia. As
summarized in Table 1B neither BBB impairment (indicated by
hemosiderin deposits and contrast enhancement), nor a glial
tumor component nor chronic epilepsy as single parameter were
paralleled by astroglial albumin accumulation. However, in GG and
DNT, which harbor all three features, glial albumin accumulation
was also detectable.
Fig. A2. Neuropathological ﬁndings in diffuse astrocytoma (WHO grade II) and metastasis of clear renal cell carcinoma. H and E staining of a diffuse astrocytoma reveals a
mildly cellular tumor with isomorph astrocytic cells (A). Strong expression of mutant IDH1 is present (B). Cytoplasm and processes show GFAP immunoreactivity (C). In
contrast, high cellularity is present in RCCM (D, H and E staining). Immunohistochemistry shows strong expression of cytokeratin in tumor cells, but not in pre-existing brain
tissue (E). GFAP immunoreactivity is restricted to non-neoplastic astrocytes (F). Scale bar = 50 mm.
Fig. A3. Neuropathological ﬁndings and GFAP/albumin double-immunohistochemistry in dysembryoplastic neuroepithelial tumors (DNT). The ‘speciﬁc glioneuronal
element’, characterized by columnar arranged oligodendroglia-like cells and ‘ﬂoating neurons’ in a pale alcianophilic matrix, represents the hallmark of DNT (A, H and E-
staining; B, alcianblue-staining). The non-dysplastic neurons are immunoreactive for NeuN (C) and the oligodendroglia-like cells show strong expression of S100-antigen (D).
An association of glial nodules with the ‘speciﬁc glioneuronal element’ has been named complex DNT variant, in which hemorrhages and contrast enhancement are more
frequent. Such glial nodules were present in all analyzed DNT samples. The glial components of the complex form often mimic low grade glioma with MAP2- (E) and GFAP-
immunoreactivity (F). Prussian blue staining highlighted hemosiderin deposits in three DNT samples (G). In lesional region of DNT astrocytes (circles in J) show a co-
localisation of GFAP (H, GFAP-staining, red) and albumin (I, albumin-staining, green) in double-immunohistochemistry (J, merged image). Intravascular albumin signals
(white arrow) can be also detected. Scale bar: A, B, E, F = 50 mm; C, D, G–J = 25 mm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to
the web version of the article).
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Fig. A4. Fluorescent double-immunohistochemistry of GLUT-1 and CD34. Combined images reveal a co-localization of GLUT-1 (green) immunoreactivity and CD34 (red)
positive vascular endothelial cells (white arrows) in lesional (A) and perilesional (B) region of ganglioglioma WHO grade I and lesional region of diffuse astrocytoma WHO
grade II (C). Characteristic satellite cells in the tumor region of gangliogliomas are strongly CD34 positive (asterisk in A). Microscopically no differences of GLUT-1 expression
between the analyzed entities were observed. Scale bar = 50 mm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of
the article).
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components as an epileptogenic mechanism? Our control
experiments revealed that low grade astroglial tumors, i.e. DA
(WHO grade II), not associated with chronic seizures, do not
show albumin uptake by tumor cells. This result may argue
for albumin uptake in GG astroglia to represent an epilepsy-
associated mechanism. However, the lack of albumin uptake
in FCD IIb glial elements suggests that astroglial albumin
uptake is not necessarily associated with epileptogenesis.
Furthermore, the absence of albumin accumulation in astro-Fig. A5. CD34/albumin double-immunohistochemistry control groups. Vascular endoth
intravascular localization of albumin signals (green) in FCD IIb (A), DA (B) and RCCM (C) as
to color in this ﬁgure legend, the reader is referred to the web version of the article).cytes within FCD IIb strongly argues against albumin uptake
by GG astroglia as an unspeciﬁc consequence of epileptic
seizures.
In RCCM, as an example of fast growing neoplasms, that
frequently demonstrate hemosiderin deposits as neuropatholog-
ical correlate of BBB dysfunction, we did not observe signiﬁcant
uptake of albumin by adjacent reactive astroglia. However,
patients with RCCM included in the present study showed acute
sporadic epileptic seizures but did not suffer from chronic
epilepsy.elial cells show strong expression of CD34 (red). Combined images conﬁrm mainly
 indicated by white arrows. Scale bars = 50 mm. (For interpretation of the references
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neocortex has been shown to generate an epileptic focus.4,11
Furthermore, artiﬁcial opening of BBB by mannitol in chronic
epileptic rats results in increased seizure frequency.5 Regarding a
potential molecular mechanism of BBB leakage and subsequent
epileptogenesis or aggravation of epilepsy, recent studies
indicated that albumin underlies the transformation of astrocytes
from a ‘‘resting’’ to a ‘‘reactive’’ state through transforming
growth factor b (TGF-b) signaling.4,8 Recent data on albumin
uptake by reactive astroglia adjacent to malformed blood vessels
argues for a phenomenon associated with long term chronic
epilepsy.10 In contrast to data from experimental animal models,
where albumin leakage is based on a transient functional BBB
disruption, in human vascular malformations10 and GG, blood
vessels are of aberrant architecture.12 These considerations may
argue for a structural BBB dysfunction in such human chronic
epilepsy associated lesions.
However, we were not able to resolve the molecular mecha-
nisms that may cause BBB dysfunction in GG. We excluded reduced
levels of GLUT-1 in GG endothelia as potential mechanism
(Fig. A4). Others, we will address in the future.
Finally, our results have certain clinical aspects. Whereas gross
total resection of GG may not always be indicated under neuro-
oncologic perspectives, albumin-containing astroglia as potential
epileptogenic cell population of GG may be neurosurgically be
minimized based on careful MRI- and EEG based mapping of the
seizure generating area prior to epilepsy-surgery. In future
attempts, anti-angiogenic treatment may provide epilepsy-thera-
py perspectives in patients with GG in functional locations.
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